Barclays
TVGN icon

Barclays’s Tevogen Inc. Common Stock TVGN Stock Holding History

Barclays’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13K Sell
249
-1,063
-81% -$13K ﹤0.01% 4896
2025
Q4 		$21.7K Buy
1,312
+171
+15% +$4.45K ﹤0.01% 4861
2025
Q3 		$44.8K Sell
1,141
-231
-17% -$11.4K ﹤0.01% 4792
2025
Q2 		$85.7K Buy
1,372
+611
+80% +$34.8K ﹤0.01% 4619
2025
Q1 		$41.1K Sell
761
-151
-17% -$9.93K ﹤0.01% 4668
2024
Q4 		$47K Buy
912
+257
+39% +$16.7K ﹤0.01% 4777
2024
Q3 		$12.1K Buy
655
+505
+337% +$14.8K ﹤0.01% 4955
2024
Q2 		$5.44K Buy
+150
New +$9.77K ﹤0.01% 4573
2023
Q1 		– Sell
-714
Closed -$369K – 5404
2022
Q4 		$369K Sell
714
-3,000
-81% -$1.54M ﹤0.01% 3498
2022
Q3 		$1.88M Hold
3,714
– – ﹤0.01% 1792
2022
Q2 		$1.86M Hold
3,714
– – ﹤0.01% 1902
2022
Q1 		$1.85M Buy
+3,714
New +$1.85M ﹤0.01% 1922

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Barclays's TVGN Position: Q1 2026 in Review

Barclays reduced its Tevogen Inc. Common Stock (TVGN) stake by 81% in Q1 2026, selling an estimated $13K and leaving 249 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #4896.

Barclays first reported a position in TVGN in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.88M in Q3 2022. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Barclays held 249 shares of Tevogen Inc. Common Stock worth $1.13K as of Q1 2026.
  • Barclays sold 1,063 Tevogen Inc. Common Stock shares in Q1 2026, an estimated $13K.
  • Tevogen Inc. Common Stock made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4896 holding.
  • Barclays first reported a position in Tevogen Inc. Common Stock in Q1 2022 and has held it in 12 quarters since.
  • Barclays's Tevogen Inc. Common Stock position peaked at $1.88M in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.